🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study will evaluate clinical efficacy, safety, tolerability and...
Status
Completed
Location
Site 14
Start Date
2007-10
Trial ID
NCT00630331
Treatments Being Tested
The purpose of this study is to describe the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02344134
Treatments Being Tested
Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Status
Completed
Location
320, Novartis Investigational Site
Start Date
2013-05
Trial ID
NCT01857206
Treatments Being Tested
Immunogenicity and safety of a cell-derived influenza vaccine in adults age...
Status
Completed
Location
Site Reference ID/Investigator# 45690
Start Date
2009-05
Trial ID
NCT00889889
Treatments Being Tested
The study primarily aims to evaluate immunogenicity and safety of influenza...
Status
Completed
Location
5
Start Date
2007-10
Trial ID
NCT00579345
The study is designed to evaluate the safety of TIVc or TIV vaccine in chil...
Status
Completed
Location
Novartis Investigational Site 022
Start Date
2013-10
Trial ID
NCT01998477
The present study is designed to confirm the safety and immunogenicity of c...
Status
Completed
Location
Rostock University, Department of Tropical Medicine and Infectious Diseases
Start Date
2013-08
Trial ID
NCT01880697
Treatments Being Tested
The present study is the first study designed to evaluate safety, tolerabil...
Status
Completed
Location
Site 09
Start Date
2007-10
Trial ID
NCT00645411
The present study aims to evaluate safety, tolerability and immunogenicity ...
Status
Completed
Location
2nd Department of Internal Diseases, Panevezys Hospital,
Start Date
2005-09
Trial ID
NCT00310804
The purpose of the study is to evaluate safety, tolerability and immunogeni...
Status
Completed
Location
Wojewódzki Szpital Dzieci_cy
Start Date
2005-09
Trial ID
NCT00306527
Treatments Being Tested